Stocks · Health care · Biological Products, (No Diagnostic Substances)

PharmaCyte Biotech, Inc.

PMCB Clue Score43
United States Fiscal year ends April CIK 0001157075

What the insiders did No buying or selling

By person

5 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Joshua Silverman
CEO and President
—
—
—
416,250
$351.15K
—
Jonathan Schechter
Director
—
—
—
192,500
$162.39K
+285.0%
Robert Weinstein
Director
—
—
—
41,250
$34.80K
—
Michael M Abecassis
Director
—
—
—
22,292
$18.81K
+1,237%
Wayne Remell Walker
Director
—
—
—
20,625
$17.40K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.